by Annie De Groot | Nov 22, 2013 | Thinking Out Loud -Blog
When H7N9 emerged, we made the discovery that H7N9 contained far fewer epitopes than other flu strains, and so we sounded an alarm – H7N9 is a stealth virus! (click on the underlined link, it will bring you to our article on the topic). It turns out that we were...
by Annie De Groot | Oct 21, 2013 | Thinking Out Loud -Blog
https://www.newscientist.com/article/mg21829164.200-us-invokes-emergency-act-to-keep-h7n9-flu-at-bay.html#.UmUyniRQ25c But there is another problem: H7 flu is poor at stimulating immunity. Virologists at the European Flu Summit in Brussels last week told New Scientist...
by Annie De Groot | Oct 17, 2013 | Thinking Out Loud -Blog
WHO: Human infection with avian influenza A(H7N9) virus – update Disease outbreak news 16 OCTOBER 2013 – The National Health and Family Planning Commission, China notified WHO of a new laboratory-confirmed case of human infection with avian influenza A(H7N9)...
by Annie De Groot | Sep 25, 2013 | News
https://convergenceri.com/ EpiVax commits resources to bring its Tregitope platform to clinic A pioneering firm in immunogenicity comes of age PHOTO BY SCOTT KINGSLEY Dr. Anne S. De Groot, CEO of EpiVax, Inc., is one of the original biotech pioneers in Rhode Island....
by Annie De Groot | May 20, 2013 | News
LIFE SCIENCES Vaccine development for H7N9 flu moving forward By Richard Asinof Contributing Writer Twitter: @RichardAsinof Posted 5/20/13 PROVIDENCE – It has been a very busy month and half for Dr. Anne S. De Groot and her team at EpiVax, a bioscience firm based in...